Drug factory · FDA FEI 3004311700
Alpex Pharma SA
Via Cantonale, Mezzovico, Switzerland
Problems found, fixed voluntarily at FDA's last inspection, Dec 14, 2023.
Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.
3 drug inspections on record since 2011: 2 with no problems, 1 with problems fixed voluntarily, 0 with FDA action.
What it does, for whom
| Drug | Role | For | NDC |
|---|---|---|---|
| Sevelamer | Makes it | Bionpharma Inc. | 69452-126, 69452-127 |
FDA inspection history
| Ended | Result | Program | Problems noted |
|---|---|---|---|
| Dec 14, 2023 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
| Aug 21, 2015 | No problems found | Drug Quality Assurance | — |
| Feb 24, 2011 | No problems found | Drug Quality Assurance | — |
Registered with FDA for: manufacture.